|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.360 USD | -1.75% |
|
+1.82% | -8.20% |
| 05-14 | Fortress Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Journey Medical Corporation secures contract with third major GPO for Emrosi | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTRESS BIOTECH, INC. | Biopharmaceuticals | -1.75% | +1.82% | -8.20% | +74.09% | -92.73% | 114M |  |  | |
- Stock Market
- Stocks
- FBIO Stock
- Charts Fortress Biotech, Inc.
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
